Charles Schwab Investment Management Inc Applied Genetic Technologies Corp Transaction History

Charles Schwab Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.07 - $2.71 $13,717 - $34,742	-12,820 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.62 - $5.23 $330,542 - $477,551	-91,310 Reduced 87.69%	12,820 $51,000
Q1 2021 May 17, 2021	BUY	$3.94 - $8.19 $140,453 - $291,957	35,648 Added 52.05%	104,130 $528,000
Q4 2020 Feb 16, 2021	BUY	$3.99 - $5.7 $21,358 - $30,512	5,353 Added 8.48%	68,482 $281,000
Q2 2020 Aug 14, 2020	BUY	$3.0 - $6.9 $189,387 - $435,590	63,129 New	63,129 $350,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.